Patient-derived models of brain metastases recapitulate human disseminated disease

Gavrilovic, 2005, Brain metastases: epidemiology and pathophysiology, J. Neurooncol., 75, 5, 10.1007/s11060-004-8093-6 Achrol, 2019, Brain metastases, Nat. Rev. Dis. Primers, 5, 5, 10.1038/s41572-018-0055-y Taillibert, 2018, Leptomeningeal metastasis, Handb. Clin. Neurol., 149, 169, 10.1016/B978-0-12-811161-1.00013-X Leal, 2011, Leptomeningeal metastasis: challenges in diagnosis and treatment, Curr. Cancer Ther. Rev., 7, 319, 10.2174/157339411797642597 Soffietti, 2020, Management of brain metastases according to molecular subtypes, Nat. Rev. Neurol., 16, 557, 10.1038/s41582-020-0391-x Lin, 2004, CNS metastases in breast cancer, J. Clin. Oncol., 22, 3608, 10.1200/JCO.2004.01.175 Lin, 2015, Treatment of brain metastases, J. Clin. Oncol., 33, 3475, 10.1200/JCO.2015.60.9503 Groves, 2010, New strategies in the management of leptomeningeal metastases, Arch. Neurol., 67, 305, 10.1001/archneurol.2010.18 Lockman, 2010, Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer, Clin. Cancer Res., 16, 5664, 10.1158/1078-0432.CCR-10-1564 Heerboth, 2015, EMT and tumor metastasis, Clin. Transl. Med., 4, 6, 10.1186/s40169-015-0048-3 Venur, 2020, Advances in management of brain and leptomeningeal metastases, Curr. Neurol. Neurosci. Rep., 20, 26, 10.1007/s11910-020-01039-1 Bos, 2009, Genes that mediate breast cancer metastasis to the brain, Nature, 459, 1005, 10.1038/nature08021 Brastianos, 2015, Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets, Cancer Discov., 5, 1164, 10.1158/2159-8290.CD-15-0369 Valiente, 2014, Serpins promote cancer cell survival and vascular co-option in brain metastasis, Cell, 156, 1002, 10.1016/j.cell.2014.01.040 Tentler, 2012, Patient-derived tumour xenografts as models for oncology drug development, Nat. Rev. Clin. Oncol., 9, 338, 10.1038/nrclinonc.2012.61 Rosfjord, 2014, Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology, Biochem. Pharmacol., 91, 135, 10.1016/j.bcp.2014.06.008 Hidalgo, 2014, Patient-derived xenograft models: an emerging platform for translational cancer research, Cancer Discov., 4, 998, 10.1158/2159-8290.CD-14-0001 Masmudi-Martin, 2021, Brain metastasis models: what should we aim to achieve better treatments?, Adv. Drug Deliv. Rev., 169, 79, 10.1016/j.addr.2020.12.002 Lai, 2017, Current status and perspectives of patient-derived xenograft models in cancer research, J. Hematol. Oncol., 10, 106, 10.1186/s13045-017-0470-7 Siolas, 2013, Patient-derived tumor xenografts: transforming clinical samples into mouse models, Cancer Res., 73, 5315, 10.1158/0008-5472.CAN-13-1069 Bruna, 2016, A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds, Cell, 167, 260, 10.1016/j.cell.2016.08.041 Rubio-Viqueira, 2006, An in vivo platform for translational drug development in pancreatic cancer, Clin. Cancer Res., 12, 4652, 10.1158/1078-0432.CCR-06-0113 Charafe-Jauffret, 2013, ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program, Cancer Res., 73, 7290, 10.1158/0008-5472.CAN-12-4704 Li, 2013, Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts, Cell Rep., 4, 1116, 10.1016/j.celrep.2013.08.022 Lee, 2015, Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy, Clin. Cancer Res., 21, 1172, 10.1158/1078-0432.CCR-14-1589 Dong, 2010, Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy, Clin. Cancer Res., 16, 1442, 10.1158/1078-0432.CCR-09-2878 Metildi, 2014, Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model, J. Surg. Oncol., 109, 451, 10.1002/jso.23507 Nicolle, 2017, Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts, Cell Rep., 21, 2458, 10.1016/j.celrep.2017.11.003 Krepler, 2017, A comprehensive patient-derived xenograft collection representing the heterogeneity of melanoma, Cell Rep., 21, 1953, 10.1016/j.celrep.2017.10.021 Ricci, 2014, Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations, Cancer Res., 74, 6980, 10.1158/0008-5472.CAN-14-0274 Contreras-Zarate, 2017, Development of novel patient-derived xenografts from breast cancer brain metastases, Front. Oncol., 7, 252, 10.3389/fonc.2017.00252 Ni, 2016, Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases, Nat. Med., 22, 723, 10.1038/nm.4120 Tew, 2020, Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones, Neuro Oncol., 22, 70, 10.1093/neuonc/noz137 Schwartz, 2016, Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation, Cancer Res., 76, 4359, 10.1158/0008-5472.CAN-16-0485 Miarka, 2021, Animal models of brain metastasis, Neurooncol. Adv., 3, v144 Blazquez, 2018, PI3K: a master regulator of brain metastasis-promoting macrophages/microglia, Glia, 66, 2438, 10.1002/glia.23485 LoRusso, 2016, Inhibition of the PI3K/AKT/mTOR pathway in solid tumors, J. Clin. Oncol., 34, 3803, 10.1200/JCO.2014.59.0018 Hu, 2020, Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases, Nat. Genet., 52, 701, 10.1038/s41588-020-0628-z McFadden, 2014, Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing, Cell, 156, 1298, 10.1016/j.cell.2014.02.031 Cleary, 2014, Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers, Nature, 508, 113, 10.1038/nature13187 Sanborn, 2015, Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination, Proc. Natl. Acad. Sci. U S A, 112, 10995, 10.1073/pnas.1508074112 Marjanovic, 2020, Emergence of a high-plasticity cell state during lung cancer evolution, Cancer Cell, 38, 229, 10.1016/j.ccell.2020.06.012 Gundem, 2015, The evolutionary history of lethal metastatic prostate cancer, Nature, 520, 353, 10.1038/nature14347 Dankner, 2021, Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases, Neuro Oncol., 23, 1470, 10.1093/neuonc/noab002 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Anders, 2015, HTSeq--a Python framework to work with high-throughput sequencing data, Bioinformatics, 31, 166, 10.1093/bioinformatics/btu638 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8